title: Pharmacology of antiplatelet agents.
abstract: Pharmacotherapies with agents that inhibit platelet function have proven to be effective in the treatment of acute coronary syndromes, and in the prevention of complications during and after percutaneous coronary intervention. Because of multiple synergetic pathways of platelet activation and their close interplay with coagulation, current treatment strategies are based not only on platelet inhibition, but also on the attenuation of procoagulant activity, inhibition of thrombin generation, and enhancement of clot dissolution. Current strategies can be broadly categorized as anticoagulants, antiplatelet agents, and fibrinolytics. This review focuses on the pharmacology of current antiplatelet therapy primarily targeting the inhibition of the enzyme cyclooxygenase 1, the P2Y12 receptor, the glycoprotein IIb/IIIa receptor, and protease-activated receptor 1.
authors.affiliation: Sinai Center for Thrombosis Research, Cardiac Catheterization Laboratory, 2401 W. Belvedere Ave, Baltimore, MD, 21215, USA.
authors.forename: Kiran
authors.initials: K
authors.lastname: Kalra
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Franzese
authors.forename: Martin G
authors.initials: MG
authors.lastname: Gesheff
authors.forename: Eli I
authors.initials: EI
authors.lastname: Lev
authors.forename: Shachi
authors.initials: S
authors.lastname: Pandya
authors.forename: Kevin P
authors.initials: KP
authors.lastname: Bliden
authors.forename: Udaya S
authors.initials: US
authors.lastname: Tantry
authors.forename: Paul A
authors.initials: PA
authors.lastname: Gurbel
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects*; D000075202:Contraindications; D006801:Humans; D015539:Platelet Activation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors